Raydiance makes major breakthrough by manufacturing bioabsorbable vascular stent materials

Oct 21 2009

Raydiance Corporation, developer of the world’s first commercial-grade ultrafast laser, announced today that it has made a major breakthrough in manufacturing a wide variety of bio-absorbable materials with precise, micron-resolution feature sizes and with no heat affected zones (HAZ).

Raydiance has been deploying its Smart Light MD^TM platform with leading medical device companies to manufacture a range of bioabsorbable vascular stent designs and materials, as well as other bio-compatible polymers.

The recent Raydiance work was performed on bioabsorbable materials such as polylactic acid, polyglycolic acid, and a variety of copolymers. The vascular stents machined by Raydiance had strut dimensions of 80 microns and less.

“The medical device industry has embarked on an exciting wave of innovation in small, extremely precise implantable devices,” said Scott Davison, president of Raydiance. “These new products and applications require a new tool that enables the machining of very small features without introducing heat to the process. Raydiance Smart Light is that tool.”

Raydiance will be discussing this advance and its ultrafast technology at the Medical Design and Manufacturing show in Minneapolis today and tomorrow. Raydiance representatives will be available in the Rofin-Sinar booth (# 1425) to answer questions. To learn more about Raydiance, please visit www.raydiance-inc.com, or to learn more about laser-based solutions for industrial materials processing, visit Rofin-Sinar. Raydiance also recently announced a partnership with leading contract manufacturer, Norman Noble, which recently chose Raydiance Smart Light as the core technology to power an advanced laser machining process, Noble UltraLight^TM.